Thomas Moriarty - Apr 1, 2022 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP & General Counsel
Signature
/s/ Thomas M. Moriarty
Stock symbol
CVS
Transactions as of
Apr 1, 2022
Transactions value $
-$6,331,570
Form type
4
Date filed
4/5/2022, 07:39 PM
Previous filing
Mar 17, 2022
Next filing
Jun 30, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock Tax liability -$10.7M -106K -12.65% $101.09 731K Apr 1, 2022 Direct F1
transaction CVS Common Stock Tax liability -$359K -3.56K -0.48% $101.09 735K Apr 3, 2022 Direct F2
holding CVS Common Stock 81.2K Apr 1, 2022 By GRAT
holding CVS Stock Unit 46.5K Apr 1, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVS Stock Option Award $4.73M +46.8K $101.09 46.8K Apr 1, 2022 Common Stock 46.8K $101.09 Direct F3
holding CVS Stock Option 71.7K Apr 1, 2022 Common Stock 71.7K $104.82 Direct F4
holding CVS Stock Option 125K Apr 1, 2022 Common Stock 125K $78.05 Direct F5
holding CVS Stock Option 36.5K Apr 1, 2022 Common Stock 36.5K $62.21 Direct F6
holding CVS Stock Option 101K Apr 1, 2022 Common Stock 101K $54.19 Direct F7
holding CVS Stock Option 148K Apr 1, 2022 Common Stock 148K $58.34 Direct F8, F9
holding CVS Stock Option 155K Apr 1, 2022 Common Stock 155K $74.30 Direct F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Surrender of shares in payment of withholding taxes due upon the vesting and settlement of the PSUs.
F2 Surrender of shares in payment of taxes due upon the vesting and settlement of PSUs on April 1, 2022.
F3 Option becomes exercisable in four equal annual installments, commencing 4/1/2023.
F4 Option became exercisable in four equal annual installments, commencing 4/1/2017.
F5 Option became exercisable in four equal annual installments, commencing 4/3/2018.
F6 Option became exercisable in four equal annual installments, commencing 4/1/2019.
F7 Option became exercisable in four equal annual installments, commencing 4/1/2020.
F8 The number of shares subject to the option were calculated using a 30-day average price.
F9 Option became exercisable in four equal annual installments, commencing 4/1/2021.
F10 Option becomes exercisable in four equal annual installments, commencing 4/1/2022.